VirusBank Platform (VBP) VirusBank Platform | VirusBank Platform is a unique research infrastructure at KU Leuven, designed to accelerate the discovery and testing of countermeasures against viruses with epidemic and pandemic potential. By uniting under one roof a comprehensive virus library, validated sequencing and molecular systems, engineered (complex) cell-based assays, as well as small-animal infection models, VBP provides an “ever-warm” capacity to respond immediately to emerging viral threats.
With support from the Novo Nordisk Foundation, this project will expand VBP’s virus collection, strengthen molecular and cellular tools, develop and validate additional small-animal infection models, and standardize all research activities under international ISO quality frameworks. These efforts will ensure that countermeasures against emerging viruses can be developed swiftly, safely, and collaboratively.
The project is led by Dr Koert Stittelaar together with Professor Johan Neyts and Dr Patrick Chaltin uniting decades of expertise in virology, antiviral discovery, and translational research to reinforce Europe’s pandemic preparedness.
The 3-year project will commence on 1st of January 2026.